Clay Siegall Builds Seattle Genetics Into A Cancer Drug Powerhouse

Clay Siegall has grown the Seattle Genetics brand into one of the biggest in America for cancer drugs, and they are using special antibody based drugs that are in trials with patients today. These patients are learning that they can see better gains in their treatment, and the company has managed to sell over $90 million in their drugs. They also have some other kinds of products coming through their distribution deals. They are very connected in the medical community in America, and they want to stay connected as much as they can.

Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors

Clay Siegall recently had a conference call with stakeholders to explain how their earnings were doing, and he shared that the company has been able to increase the range of its trials so that they can reach more people. Reaching more people will mean saving more lives, and the company will continue to get results that other people could only dream of.

They are seeing many patients get better, and they are able to release two cancer drugs at once that fight two different types of cancer. They are fighting lymphoma and breast cancer in two different arenas, and it makes them the best crusaders in the cancer drug industry today. It is very easy for people to get better using drugs from Seattle Genetics, and Clay Siegall has proven himself to be one of the best researchers in the industry with his antibody drugs.

Clay Siegall and Seattle Genetics are now on a path that will include releasing even more drugs to the market that might fight other types of cancer. It is very simple to take these drugs, and doctors are coming to trust the people at Seattle Genetics over other companies. Their trust is making Seattle Genetics into the best place to shop for new medications.

Connect with Clay Siegall:

http://www.bloomberg.com/research/stocks/people/person.asp?personId=607509&privcapId=34145